Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab Luis Figuero-Pérez, Alejandro Olivares-Hernández, Roberto A. Escala-Cornejo, Eduardo Terán-Brage, Álvaro López-Gutiérrez, Juan J. Cruz-Hernández

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment Ismael Francisco Aomar-Millán, Juan Salvatierra, José Luis Callejas-Rubio, Enrique Raya-Álvarez

Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19 Alejandro Muñoz-Jiménez, Esteban Rubio-Romero, José Luis Marenco de la Fuente